PerkinElmer and TPM Biotech SDN. BHD. Sign Agreement to Validate Porcine Detection Kits as Screening Application for Halal Food Products

WALTHAM, Mass.- PerkinElmer, Inc., a global leader focused on improving the health and safety of people and the environment, today announced that it has entered into an agreement with TPM Biotech SDN. BHD. (TPMB), a leading Malaysian laboratory for Halal food testing services, to explore potential applications of PerkinElmer's Porcine Detection Kits and chromatography solutions [...]

Shimadzu Scientific Instruments and The University of Texas at Arlington Form Shimadzu Center for Advanced Analytical Chemistry

COLUMBIA, Md --Shimadzu Scientific Instruments announces today the grand opening of the Shimadzu Center for Advanced Analytical Chemistry at The University of Texas at Arlington. Located in the university’s Chemistry & Physics Building, the center contains $6 million of chromatography, mass spectrometry and spectroscopy equipment, which is the largest installation of Shimadzu analytical instrumentation in [...]

NanoString Technologies Names Joseph M. Beechem Senior Vice President of R&D

SEATTLE, Wash.,– NanoString Technologies, Inc., a privately held provider of life science tools for translational research and developer of molecular diagnostics, today announced the appointment of Joseph M. Beechem, Ph.D. as Senior Vice President of Research and Development. An industry veteran, Dr. Beechem will be responsible for establishing and executing the company’s technology and product [...]

CommonMind Consortium Launched as a Public-Private Effort to Generate and Broadly Share Molecular Data on Neuropsychiatric Disease.

SEATTLE, WA. Sage Bionetworks, Mount Sinai School of Medicine (MSSM), University of Pennsylvania (Penn), the National Institute of Mental Health (NIMH), and Takeda Pharmaceuticals Company Limited (TAKEDA) have launched a Public-Private Pre-Competitive Consortium to generate and analyze large-scale genomic data from human subjects with neuropsychiatric disease and to make this data and the associated analytical [...]

NSG Precision Cells Releases New Screw Cap Absorbance Cuvette

NSG Precision Cells, a leader in the silicon industry, is pleased to announce their new innovative screw cap absorbance cuvette. With over 50 years’ experience and expertise, NSG Precision Cells is recognized as a frontrunner in advanced quartz technology and quality products. NSG’s absorption cuvette is made from the finest Extrasil (ES) Quartz and handmade [...]

Ironridge BioPharma to Invest $500,000 in Pressure BioSciences

SOUTH EASTON, Mass.— Pressure BioSciences, Inc.(“PBI” or the “Company”) today announced that it has entered into a definitive agreement with Ironridge BioPharma Co. (“Ironridge”) to purchase $500,000.00 in shares of Series E Convertible Preferred Stock (the “Preferred Stock”) of the Company. Each share of the 500 shares of Preferred Stock to be sold to Ironridge [...]

Illumina’s Board of Directors Sends Fourth Letter to Stockholders

RECOMMENDS STOCKHOLDERS REJECT ROCHE’S OFFER AND VOTE WHITE PROXY CARD SAN DIEGO -- Illumina, Inc. (NASDAQ:ILMN), a leading developer, manufacturer, and marketer of life science tools and integrated systems for the analysis of genetic variation and function, today is sending a letter from its Board of Directors highlighting supportive reports issued by two of the [...]

Leading Proxy Advisory Firms Issue Reports in Strong Support of Illumina

SAN DIEGO -- Illumina, Inc. (NASDAQ: ILMN), a leading developer, manufacturer and marketer of life science tools and integrated systems for the analysis of genetic variation and function, today announced that Institutional Shareholder Services Inc. (“ISS”) considers the Roche offer to acquire Illumina inadequate and has recommended that its clients support the re-election of Illumina’s [...]

Roche disappointed with ISS recommendation

Roche released the following statement in response to a report issued by Institutional Shareholder Services (“ISS”) recommending that shareholders of Illumina, Inc. (NASDAQ: ILMN) vote against the election of Roche’s independent director nominees to Illumina’s Board of Directors: “While we are disappointed that ISS has recommended that Illumina shareholders vote against our director nominees at [...]

Nano3D Biosciences Announces Next Generation in 3D Cell Culturing Equipment for the Life Science Research and Drug Discovery Market

Nano3D BiosciencesTM (n3D), a company that specializes in three-dimensional (3D) cell culturing technology for the drug discovery, toxicology, and life science research markets, announces the release of its 24-well Bio-AssemblerTM. “We are very excited about this product release as it represents a significant milestone for our company from both a scientific and business perspective. The [...]

Access IBO on Knowledge Center